Research Library

Peptide Stacking for Muscle Growth: Research Guide
Compound Guides Protocol Research GH Secretagogues Tissue Research Last Updated: May 2026 Peptide stacking for muscle growth is one of the most searched topics in the research chemical space — and also one of the most poorly understood, because the "stacking" framing obscures what the science is actually describing: mechanistically independent compound pairings that activate distinct biological pathways simultaneously. In the preclinical literature, these multi-compound research combinations are investigated not because two peptides are "better than one" in some vague sense, but because their receptor targets don't overlap — which... Read more...
BPC-157 Dosing for Research: Protocol Guide
BPC-157 Research Protocol Tissue Research Compound Guide Dosing Research Last Updated: May 2026 BPC-157 is a synthetic 15-amino acid peptide derived from a gastric cytoprotective protein, with one of the most extensive preclinical research records of any compound in the tissue-repair peptide literature — spanning more than 40 published animal studies produced primarily by the Zagreb group (Sikiric et al.) since 1994. What separates BPC-157 from most synthetic peptides in research is its documented oral bioactivity: unlike the majority of peptides that are degraded in the gastrointestinal tract, BPC-157 maintains... Read more...
Selank: Anxiolytic Peptide & Cognitive Research Overview
Compound Guide Cognitive Research Anxiolytic Research Last Updated: May 2026 Selank is a synthetic heptapeptide analogue of tuftsin — a naturally occurring immunomodulatory tetrapeptide — that has been studied extensively in preclinical research for its anxiolytic profile, GABAergic modulation, enkephalinase inhibition, and cognitive enhancement properties. Developed at Russia's Institute of Molecular Genetics, Selank 10mg carries the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro — the natural tuftsin tetrapeptide (Thr-Lys-Pro-Arg) extended by three amino acids to improve metabolic stability and CNS bioavailability. Research literature documents a compound that modulates anxiety-related behaviour in rodent models without the... Read more...
Semax: Neuropeptide for Cognitive Enhancement Research
        Compound Guide     Cognitive Research     Neuropeptide     Last Updated: May 2026           Semax is a synthetic heptapeptide analogue of ACTH(4-10) — sequence Met-Glu-His-Phe-Pro-Gly-Pro — developed at the Institute of Molecular Genetics in Russia during the 1980s and 1990s, and subsequently approved in Russia for neurological research applications including stroke intervention and cognitive deficit models. Unlike native ACTH fragments, Semax incorporates a C-terminal Pro-Gly-Pro extension that confers resistance to dipeptidyl peptidase IV (DPP-IV) enzymatic degradation, dramatically extending its biological... Read more...
Growth Hormone Peptides: GHRP-2 vs Ipamorelin Research Guide
        Compound Guide     Growth Hormone Research     Research Comparison     Last Updated: May 2026           GHRP-2 and Ipamorelin are both growth hormone secretagogues that stimulate GH release by activating the ghrelin receptor (GHS-R1a) — but they differ critically in receptor selectivity, co-stimulation of cortisol and prolactin, and their pharmacological specificity profiles. GHRP-2 is a first-generation synthetic hexapeptide with strong GH-releasing activity accompanied by dose-dependent stimulation of cortisol and prolactin. Ipamorelin is a third-generation pentapeptide engineered specifically to maximise GHS-R1a... Read more...
Peptides for Joint Recovery Research: BPC-157 vs TB-500
        Compound Guide     Joint Research     Research Comparison     Last Updated: May 2026           Joint and connective tissue research represents one of the most active areas of peptide preclinical investigation, and two compounds dominate the published evidence base: BPC-157 and TB-500. Both have been studied in a range of musculoskeletal injury models — tendon, ligament, cartilage, and bone — but they do so via distinct molecular pathways, with different published evidence profiles, different model systems, and different mechanistic implications... Read more...
Growth Hormone Peptides: GHRP-2 vs Ipamorelin Research Guide
Compound Guide Growth Hormone Research Research Comparison Last Updated: May 2026 GHRP-2 and Ipamorelin are both growth hormone secretagogues that stimulate GH release by activating the ghrelin receptor (GHS-R1a) — but they differ critically in receptor selectivity, co-stimulation of cortisol and prolactin, and their pharmacological specificity profiles. GHRP-2 is a first-generation synthetic hexapeptide with strong GH-releasing activity accompanied by dose-dependent stimulation of cortisol and prolactin. Ipamorelin is a third-generation pentapeptide engineered specifically to maximise GHS-R1a selectivity while minimising off-target pituitary hormone release — a selectivity profile that has made it... Read more...
GHRP-2 Research Protocol: Mechanism, Trial Parameters & GH Axis
Growth Hormone Research Research Protocol Compound Guide Last Updated: May 2026 GHRP-2 (Growth Hormone Releasing Peptide-2, also known as pralmorelin) is a synthetic hexapeptide that acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a), stimulating pulsatile growth hormone release through a mechanism distinct from — and synergistic with — the endogenous GHRH pathway. First characterised by Cyril Bowers in the early 1980s as part of the original enkephalin-derived GH-releasing series, GHRP-2 has since accumulated one of the most robust preclinical and clinical evidence bases among synthetic GH... Read more...
Peptide Stacking for Muscle Research: BPC-157, TB-500, Ipamorelin & CJC-1295
Research Combination Muscle Research Compound Guide Last Updated: May 2026 Multi-peptide research combination protocols — sometimes called "peptide stacking" in the research community — are preclinical study designs that administer two or more mechanistically distinct peptides to investigate whether independent signalling pathways produce complementary or additive effects in a given tissue or biological model. In muscle and connective tissue research, these protocols have become increasingly common as the published evidence base for individual compounds has matured enough to motivate investigation of their interactions. This article covers the scientific rationale for... Read more...
Tirzepatide (Mounjaro) Research: Mechanism, Clinical Data & Trial Parameters
GLP-1 Research Metabolic Research Clinical Evidence Last Updated: May 2026 Tirzepatide — marketed as Mounjaro for type 2 diabetes and Zepbound for obesity — is a 39-amino acid synthetic peptide that acts as a dual agonist at both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor, representing the first of a novel class of twincretin compounds in clinical research. Published across the SURPASS and SURMOUNT trial programmes involving over 12,000 participants, tirzepatide has generated one of the most extensively characterised metabolic efficacy profiles of any peptide... Read more...
IGF-1 LR3 Research: Mechanism, GH Axis, and Muscle Biology
IGF-1 Research GH Axis Anabolic Signalling Last Updated: May 2026 IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is an 83-amino acid synthetic analogue of human IGF-1, engineered with two structural modifications — an N-terminal 13-amino acid extension and a glutamic acid to arginine substitution at position 3 — that reduce binding to IGF-1 binding proteins and extend plasma half-life from approximately 15 minutes (native IGF-1) to 20–30 hours. This pharmacokinetic modification makes IGF-1 LR3 the primary IGF-1 analogue used in published research investigating the downstream anabolic signalling of the GH/IGF-1... Read more...
GHRP-6 vs GHRP-2: Research Comparison, Mechanism & GH Pulse Data
Compound Comparison GH Research Research Protocol Last Updated: May 2026 GHRP-6 and GHRP-2 are both synthetic hexapeptide agonists at the growth hormone secretagogue receptor type 1a (GHS-R1a), but published comparative research consistently demonstrates that GHRP-2 produces substantially higher GH pulse amplitudes — 6–10× above baseline versus 2–5× for GHRP-6 at equivalent molar doses — while generating a cleaner hormonal profile with less pronounced appetite stimulation and lower cortisol co-elevation. The distinction matters for research design: if the endpoint is maximum GH pulse amplitude, GHRP-2 is the superior tool. If appetite... Read more...
BPC-157 + TB-500: The Wolverine Recovery Research Stack Explained
Recovery Research Compound Combination Tissue Repair Last Updated: May 2026 BPC-157 and TB-500 are the two most extensively published synthetic peptides in musculoskeletal and soft tissue injury research, and they work through completely different mechanisms — making their combination the most scientifically coherent dual-compound research protocol in the injury repair literature. BPC-157 drives localised angiogenesis and growth factor upregulation at the injury site; TB-500 promotes systemic actin polymerisation, cell migration, and anti-inflammatory signalling. Together, they address the two primary rate-limiting steps in tissue repair that either compound cannot target alone.... Read more...
BPC-157 + TB-500 for Injury Research
Research Combination Injury Research Compound Guide Last Updated: May 2026 The "Wolverine Protocol" is a research community term for the combined investigation of BPC-157 and TB-500 - two synthetic peptides that have generated the most substantial published preclinical evidence base in musculoskeletal and soft tissue injury research contexts. The name is colloquial and informal, originating from online research communities referencing the Marvel character's accelerated tissue recovery. As a scientific description it is imprecise; as a search term it has become the dominant entry point for researchers and biology-curious individuals looking... Read more...
HGH Frag 176-191: What Researchers Need to Know
Compound Guide Growth Hormone Research Fragment Peptides Last Updated: May 2026 Research Use Only HGH fragment 176-191 is supplied by Pure Grade Labs strictly as a research chemical for laboratory use only. Not for human consumption. No medical claims are made. This article is educational in nature and does not constitute medical advice. HGH fragment 176-191 — commonly referred to in research literature as HGH frag or AOD-9604 precursor — is a 16-amino acid synthetic peptide derived from the C-terminal region of the full 191-amino acid human growth hormone (hGH)... Read more...
Retatrutide (Reta): Triple Incretin Research Guide
Compound Guide GLP-1 Research Clinical Evidence Last Updated: May 2026 Regulatory Notice Retatrutide is a Prescription-Only Medicine in many jurisdictions and is currently in Phase III clinical trials. This compound is supplied by Pure Grade Labs strictly as a research chemical. For research purposes only. Not for human consumption. Retatrutide — colloquially known as Reta — is a once-weekly triple incretin receptor agonist developed by Eli Lilly that simultaneously activates GLP-1R, GIPR, and the glucagon receptor (GcgR), making it the first published compound to achieve pharmacological tri-agonism across all three... Read more...
CJC-1295 DAC: Complete Research Guide & Mechanism Overview
Compound Guide GH Research GHRH Research Last Updated: May 2026 CJC-1295 with DAC (also written CJC1295 DAC) is a synthetic analogue of growth hormone releasing hormone (GHRH) engineered to resist enzymatic degradation and bind serum albumin, extending its half-life from under 10 minutes to approximately 6-8 days in published human pharmacokinetic studies. The DAC (Drug Affinity Complex) technology - a maleimidopropionic acid linker enabling covalent albumin binding - represents the same half-life extension strategy used in semaglutide, applied here to the GHRH axis rather than the GLP-1 axis. The result... Read more...
Ipamorelin Research: GH Secretagogue Mechanism & Evidence
Compound Guide GH Research Mechanism of Action Last Updated: May 2026 Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that selectively activates the ghrelin receptor (GHSR-1a) to stimulate pulsatile growth hormone release — distinguished in published literature from earlier GHRPs by its high receptor selectivity and minimal effect on cortisol, prolactin, and ACTH at research doses. First characterised by Raun K et al. in 1998, ipamorelin's selectivity profile has made it one of the most studied GH secretagogues for research contexts where isolating GH pathway effects without concurrent stress hormone... Read more...
TB-500 vs BPC-157: Mechanism & Research Comparison
Comparison Study Clinical Evidence Tissue Research Last Updated: May 2026 TB-500 (also written TB500) and BPC-157 (also written BPC157) are the two most extensively studied synthetic peptides in musculoskeletal and connective tissue research — but they work through entirely different mechanisms, have different molecular origins, and are most accurately understood as complementary research tools rather than interchangeable compounds. Understanding the distinction matters for research design: choosing between them depends on which biological pathway you are investigating, not simply which tissue type you are studying. This article compares TB-500 and BPC-157... Read more...
Semaglutide (Ozempic) Research: GLP-1 Receptor Mechanism Explained
Compound Guide Clinical Evidence GLP-1 Research Last Updated: May 2026 Regulatory Notice Semaglutide is a prescription-only medication in many jurisdictions, including the UK. This compound is supplied by Pure Grade Labs strictly as a research chemical. For research purposes only. Not for human consumption. Semaglutide — the active molecule in Ozempic, Wegovy, and Rybelsus — is a GLP-1 receptor agonist that became one of the most clinically studied compounds of the past decade, generating data across more than 10 major randomised controlled trials involving tens of thousands of participants. The... Read more...
BPC-157 Mechanism & Research: 30 Years of Preclinical Evidence
Compound Guide Clinical Evidence Mechanism of Action Last Updated: May 2026 BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic pentadecapeptide derived from a protective sequence found in human gastric juice, with over 30 years of published preclinical research across musculoskeletal, gastrointestinal, and neurological models. First characterised by Professor Predrag Sikiric and his team at the University of Zagreb in the early 1990s, BPC-157 has accumulated one of the largest preclinical evidence bases of any synthetic peptide — with more than 100 peer-reviewed publications examining its molecular mechanisms across multiple... Read more...
Wolverine Protocol: BPC-157 and TB-500 Stack - What the Research Shows
Research Peptide Mechanisms Tissue Repair Last Updated: May 2026 The combination of BPC-157 and TB-500 has generated significant research interest in the context of tissue repair mechanisms. These two peptides have accumulated extensive preclinical research compared to most stacked pairs in laboratory contexts. This article covers what published data demonstrates—the mechanistic rationale, the research studies, and why scientists consider these two compounds complementary rather than redundant in their biological pathways. Research-Grade BPC-157 and TB-500 Pure Grade Labs supplies verified purity peptides for research purposes. Every batch is third-party tested with... Read more...
AOD-9604 Research Guide — HGH Fragment for Metabolic Studies
AOD-9604 HGH Fragment Fat Metabolism Last Updated: May 2026 AOD-9604 (CAS: 221231-10-3) is a synthetic 16-amino acid peptide fragment of human growth hormone, engineered to isolate fat-metabolising properties without activating the growth hormone receptor or raising IGF-1 levels. Preclinical research showed significant lipolytic effects in animal models. Six human clinical trials enrolled over 900 participants and confirmed the safety profile. AOD-9604 is closely related to HGH Fragment 176-191, though they differ chemically in important ways. Key Takeaways CAS number: 221231-10-3. Molecular weight: ~1,817 Da. 16 amino acids (Tyr-hGH 177-191). Source:... Read more...
UK Peptide Research: A Beginner's Complete Guide
Research Education Peptide Basics UK Compliance Last Updated: April 2026 Research peptides are short chains of amino acids used in laboratory and scientific research to study biological processes including tissue repair, hormone signalling, fat metabolism, and neuroprotection. In the UK, they are legal to purchase for research purposes, are not classified as controlled substances under the Misuse of Drugs Act 1971, and are available from specialist suppliers with third-party purity verification. This guide covers everything from the biology up: what peptides are, how different categories work, what a Certificate of... Read more...
FOXO4-DRI: The Senolytic Peptide Compound Explained
Research Senolytic Peptides Cellular Senescence Last Updated: May 2026 FOXO4-DRI Senolytic Peptide: Mechanism, Research & Clinical Data FOXO4-DRI is a synthetic senolytic peptide engineered to selectively eliminate senescent cells—the "zombie" cells that stop dividing but pump out inflammatory signals that accelerate tissue ageing. By disrupting the FOXO4-p53 interaction, FOXO4-DRI triggers apoptosis in senescent cells while leaving healthy cells unharmed. This research guide covers the mechanism, published evidence, and everything you need to know about sourcing research-grade FOXO4-DRI. Key Takeaways FOXO4-DRI is a D-retro-inverso peptide (43 amino acids, all D-enantiomers) that... Read more...
Peptides for Injury Recovery Research: 2026 Overview
Research Peptide Mechanisms Comparison Last Updated: May 2026 Three synthetic peptides dominate published research on tissue repair: BPC-157, TB-500, and GHK-Cu. Each operates through a distinct primary mechanism—BPC-157 drives angiogenesis via VEGFR2 activation, TB-500 recruits repair cells through G-actin sequestration, and GHK-Cu rebuilds structural matrix through copper-dependent gene modulation. Together, they address three different rate-limiting steps in the tissue repair cascade, which is why research groups studying comprehensive healing increasingly examine all three in combination. Key Takeaways BPC-157 (CAS: 137525-51-0): 544 published articles, strongest musculoskeletal evidence via VEGFR2 angiogenesis TB-500... Read more...
What Is Retatrutide? The Next-Generation GLP-1 Compound
Clinical Evidence Triple-Receptor Mechanism UK Regulatory Status Last Updated: May 2026 Retatrutide is a triple-receptor agonist that activates GLP-1, GIP, and glucagon simultaneously—producing 28.7% mean weight loss in Phase 3 trials, the largest result ever recorded in obesity pharmacotherapy. It differs from semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP) by adding glucagon receptor activation, which drives energy expenditure and hepatic fat oxidation—mechanisms neither semaglutide nor tirzepatide can replicate. As of May 2026, retatrutide has not received UK MHRA approval and is not available on prescription. This guide covers the... Read more...
BPC Peptide: Complete Mechanism & Research Guide
BPC Peptide: Complete Mechanism & Research Guide For research purposes only. These products are sold as research chemicals and are not approved for human consumption. BPC peptide, also known as BPC-157, is a synthetic 15-amino acid peptide derived from a protective compound naturally found in gastric juice. In research settings, BPC peptide has demonstrated remarkable capacity to accelerate tissue repair across multiple biological systems — from tendon and ligament damage to gut barrier dysfunction to muscle injury recovery. The research data is compelling: BPC-157 activates growth factor pathways that trigger... Read more...
CJC-1295 and Ipamorelin: The Research Stack Explained
GH Secretagogues Peptide Stack Mechanism Research Protocol Last Updated: May 2026 CJC-1295 and Ipamorelin are the two most commonly researched growth hormone peptides — and when combined, they produce 2–10x greater GH output than either compound alone. CJC-1295 amplifies the amplitude of each GH pulse. Ipamorelin triggers the pulse itself. Together, they work through two separate receptor pathways to produce a synergistic effect that neither can replicate independently. Most people researching this stack have already heard the claims. What they haven't seen is a clean breakdown of the actual mechanism,... Read more...
How to Reconstitute Peptides: Step-by-Step Guide
Reconstitution Guide Research Protocol Bacteriostatic Water Last Updated: May 2026 Reconstituting a peptide means dissolving a lyophilized (freeze-dried) powder into a liquid solution so it can be measured and used in research applications. The process takes under 10 minutes and requires bacteriostatic water, two different needle sizes, and a basic concentration calculation done before you touch anything. This guide covers every step in the correct order, the volume calculations needed to reach a target concentration, the right needle sizes for each stage, and how to store reconstituted peptides properly. Follow... Read more...
TB-500 vs BPC-157: What the Research Shows (2026)
Peptide Comparison Mechanism Research Tissue Repair Last Updated: April 2026 TB-500 and BPC-157 are two of the most studied research peptides available in the UK. They operate through entirely different mechanisms — TB-500 works primarily through actin regulation and cell migration, while BPC-157 works through VEGFR2-mediated angiogenesis and nitric oxide system modulation. Their research applications overlap in musculoskeletal models but are not identical. If you are comparing these two compounds, you are probably trying to understand what separates them, where the evidence is strongest for each, and whether the research... Read more...
Are Peptides Legal in the UK? Complete 2026 Guide
UK Peptide Law Research Chemicals Compliance Last Updated: April 2026 Most research peptides — including BPC-157, TB-500, CJC-1295, and Ipamorelin — are legal to buy and possess in the UK in 2026. They are not controlled substances under the Misuse of Drugs Act 1971. The legal line sits not in the molecule itself, but in how it is sold, marketed, and labelled. Sell a peptide for human use without MHRA approval, and you are breaking the law. Sell it clearly as a research chemical for laboratory use, and you are... Read more...
BPC-157 UK: Complete Research Guide (2026)
Peptide Mechanism Tissue Repair Research Lab Protocol Last Updated: April 2026 BPC-157 (CAS: 137525-51-0) is a synthetic 15-amino acid peptide derived from a protective protein found in human gastric juice. First characterised in 1993 by Sikiric et al. at the University of Zagreb, it is one of the most extensively studied research peptides available in the UK, with over 544 published articles indexed across PubMed, Cochrane, and Embase as of 2025. It is available in the UK as a research chemical for laboratory use. It is not a licensed medicine,... Read more...